MDLinx, a Part of M3 Group, Partners with MMIT to Offer Pharmaceutical Brands Targeted Formulary Information for Healthcare Professionals

September 23, 2013

Two trusted industry leaders team up to deliver valuable formulary data to help physicians make more informed prescribing decisions for their patients

(Washington, DC, Yardley, PA September 23, 2013)– Every day MDLinx, (, educates and updates nearly half a million US Healthcare based professionals with trusted clinical and medical information. MMIT ( provides trusted formulary data and software solutions to payers, pharmaceutical manufacturers and physicians to help them make informed managed care decisions. Together, the combination delivers MMIT’s high integrity information directly to hundreds of thousands of physicians via MDLinx – the #1 ranked specialty website.

“We are excited to partner with MMIT as they continue to expand their managed market offerings and their growing customer base,” comments Aki Tomaru, CEO of M3 USA.

“Pharmaceutical companies will now have a way to leverage their contracting wins and advantaged formulary status through a doctor trusted network,” said Jeff Steinberg, CEO of MMIT. “Our partnership with MDLinx is a valuable extension of MMIT’s existing pull through platform, one which will provide clients geographically targeted access to the specialists that they want to reach. Most importantly, the tight bundling of online promotional messaging, rebating, and field sales force reinforcement will enhance the ROI of our client’s largest marketing investments.”

The need for timely targeted access to formulary information continues to grow in importance for physicians, helping them make more informed pharmaceutical product choices for their patients. This powerful new promotional partnership will give more pharma brands the opportunity to run targeted campaigns utilizing MMIT’s data with the extensive HCP coverage of MDLinx.

About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 1.2 million physician members globally via its physician websites such as,,, and MDLinx is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

About MMIT
MMIT provides complete and accurate market access information to the rapidly changing healthcare market. Payers, pharmaceutical manufacturers, healthcare providers and pharmacies use MMIT’s information in important business and decision-making processes to gain the key insights needed to navigate the market’s reforms. Our solutions are used from P&T through to point of care – ensuring consistent, informed managed care decisions across the healthcare spectrum. MMIT is located in Yardley, PA.